New NCAB Task Force On Clinical Trials Is Attempt To Bring NCI, Groups Together
In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators
NSABP Investigator Recounts Loyalty To Fisher, “Betrayal”
NCAB Member Seeks Broder’s Resignation, Gets No support
Pittsburgh Broadens Misconduct Inquiry
Senate Appropriators Plan Hearing On NCI Ouster Of Fisher
DCE director Adamson To Retire August 31
DCPC Advisor O Trial Of Cervical Lesion Management With HPV
Trending Stories
- Trump administration is removing the mainstays of NCI and the federal government’s cancer program
Peer review, registries, and evidence-based patient information take a big hit - NIH eliminates the NCI Board of Scientific Advisors
Over its 28 year history, BSA shaped NCI-funded extramural science - Bhattacharya cancels NIH all-hands meeting
- Cyber-iconoclast Vinay Prasad named head of FDA’s CBER
An oncologist, Prasad has criticized accelerated approval, next-gen sequencing, and targeted therapies - In the Headlines: “There’s no one to stand up for NCI right now.”
- George Weiner: Cancer centers are special, as are site visits in CCSG review